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Scott, P. H., Berger, H. M., Kenward, C., Scott, P., and Wharton, B. A. (1975) . Archives of Disease in Childhood, 50, 796. Effect of gestational age and intrauterine nutrition on plasma transferrin and iron in the newborn. Plasma concentrations of transferrin and iron were measured in the cord blood of babies of varying gestational age and birthweight. Transferrin and iron concentrations rose with gestational age; values in light-for-dates babies did not differ from those in babies of appropriate weight. In the last trimester of pregnancy plasma transferrin and iron concentrations in the fetus are affected by the maturity of the pregnancy but are independent of the nutritional status of the fetus. The low transferrin levels, particularly in preterm babies, may caution the use of iron especially by the parenteral route in the neonatal period, but we are wary of abandoning on this evidence alone the well tried clincial custom of giving oral iron to preterm babies who are not breast fed.
The anti-infective property of transferrin as part of the nonspecific defence system (Fletcher, 1971 ) may be particularly important in the small preterm baby since more specific anti-infective substances, such as the serum immunoglobulins, are present in reduced concentrations in these babies and infection is a common complication (Hobbs and Davis, 1967; Davies, 1971 January and September 1974. The gestational age of the babies was assessed by mother's dates, and confirmed by the obstetrician's antenatal, and the paediatrician's postnatal, assessment ofmaturity. Birthweight was measured with a Salter spring balance and the babies designated as appropriate weight-for-dates (weight for gestational age, sex, and parity 10-90th centile according to data of Tanner and Thomson, 1970) or light-for-dates (weight for gestation, etc. < 10th centile). Of the term babies (37-41 completed weeks) 31 (47%) were Asian and 8 (12%) West Indian; of the preterm ones (<37 weeks) 12 (30%) were Asian, 5 (13%) West Indian, the rest were European. The blood was collected by needle aspiration of the umbilical vein, and placed in a heparinized container. This was stored at 4°C until the plasma was separated (within 36 hours). The plasma was stored at -20°C until analysis.
Transferrin concentrations were measured by a single radial immunodiffusion technique (Mancini, Carbonara, and Heremans, 1965) using Behringwerke M Partigen plates (Hoechst Pharmaceuticals Ltd). Each plate was standardized using standard human serum (Hoechst). Iron concentrations were determined by the method of Askevold and Vellor (1967) . Percentage transferrin saturations were calculated assuming 1 mg transferrin when fully saturated binds 1*4 pg iron (Dixon, 1973 Zi, 50- In term babies (37-41 completed weeks) transferrin in light-for-dates group was (mean ± SD, mg/100 ml) 210±45 and in appropriate weight group 200±36, not significant; iron in light-for-dates group was 145±44 tigl 100 ml and in appropriate weight group was 151 ±41, not significant.
Individual results did not show any racial differences. Discussion In the term babies the concentrations of iron were similar to those reported previously (Csorba, Jezerniczky and Dvoracsek, 1973; Chang and Sivasamboo, 1973) and transferrin concentrations were a little higher. Low concentrations of iron and transferrin have been reported in low birthweight babies (Csorba et al., 1973; Weippl, 1962) , but the findings were not related to the presently accepted divisions of low birthweight babies into 'preterm' and 'light-for-dates' categories (European Congress of Perinatal Medicine, 1970).
Developmental biology. Our observations show that the serum transferrin rises with gestational age; since transferrin is thought not to cross the placenta in man (Gitlin et al., 1964) , this rise presumably reflects an increasing rate of synthesis by the liver. The serum iron concentration increased in parallel with the transferrin. The plasma transferrin level and its degree of saturation are probably the rate-limiting steps in intestinal iron absorption (Nutrition Review, 1973; Fletcher and Huehns, 1968) so that the increase in fetal transferrin with increasing maturity might similarly determine the amount of iron transported across the placenta, and hence the increase in fetal iron stores during that period (Oski and Naiman, 1972) .
Transferrin was not lower in the malnourished (light-for-dates) babies. It is interesting, however, that mothers producing a low birthweight baby may have low levels of serum transferrin at midpregnancy (Maletnlema and Eddy, 1972) and at term (Chang and Sivasamboo, 1973) , though it is unclear whether the serum transferrin is reflecting the nutritional status of the mother at that time.
Clinical implications. Although the transferrin levels rose with gestational age, the scatter of results was too wide for clinical use in determining maturity, nor were the levels useful in assessing nutritional status.
The low level of transferrin, particularly as it was well saturated (mean 5900 compared to about 40% in the adult; Oski and Naiman, 1972) might be related to the problem of infection in preterm babies. The concentration was very low in some individuals and it is known that it falls even further for a few days after birth before rising again, e.g. in a group of 29 preterm babies and 19 light-for-dates term babies receiving infant formulae containing iron approximately 1 mg/100 ml* we found the plasma transferrin at 11 days to be about 85 % of that found at birth with a return to near birth levels at 21 days.
It may be in these circumstances that any measures leading to an increased transferrin saturation would prejudice further the nonspecific antiinfective role of transferrin. This would caution the use of iron (either by individual prescription or as fortification of infant formulae) in the neonatal period. However, even after the use of oral iron it seems that the degree of transferrin saturation in low birthweight babies is very low (Brozovic et al., 1974) . Furthermore, iron deficiency is associated with depressed white cell function in older children (Chandra, 1973) and depressed antibody production in rats (Nalder et al., 1972) . We feel, therefore, we should be wary of abandoning, on the transferrin evidence alone, the well tried custom of giving supplementary oral iron to low birthweight babies who are not receiving fresh breast milk. However, our understanding of the biological functions of iron and its binding proteins in this age group is changing rapidly so that current clinical practice must be kept under review.
Parenteral iron gives a greater degree of saturation (Leikin, 1960 ) and we do not use it at this age, nor is oral iron given to breast-fed babies, so avoiding saturation of the lactoferrin in the breast milk (Bullen, Rogers and Leigh, 1972 
